Onbrez 150mcg

Onbrez 150 mcg is a prescription drug used for maintenance bronchodilator treatment of airflow obstruction in adult patients with chronic obstructive pulmonary disease or COPD. In COPD, the muscles around the airways in the lungs become tight. Onbrez contains the active ingredient indacaterol, which belongs to a class of medications known as bronchodilators. When you inhale the drug, it causes the relaxation of muscles in the walls of the small air passages in the lungs. This helps open the airways in the lungs, making it easier for them to receive air in and out.  

The recommended dose in the inhalation is the content of one 150 mcg capsule once daily, using the Onbrez Breezhaler inhaler. The Breezhaler should be used at the same time each day. No dose adjustment is needed for patients with mild to moderate liver and kidney problems.  

Method of administration

Onbrez capsules are for inhalation use only. In its pack, you will find inhaler capsules that contain the medicine in the form of inhalation powder. Only use the capsules with the inhaler provided in the pack of the Onbrez Breezhaler inhalers. The capsules should remain the blister until you need to use them.

These capsules should not be swallowed. Onbrez capsules must be administered only using the Onbrez Breezhaler inhaler. Patients should be instructed on how to use the product correctly. Their doctors may ask those who can’t see improvement in breathing if they are swallowing the medicines rather than inhaling them. Breezhaler is used as an ongoing treatment for your COPD. Do not use the inhaler medicine to treat a sudden attack of wheezing and breathlessness.

Keep using Breezhaler for as long as your doctor tells you. COPD is a long-term disease, and you should use the Breezhaler daily and not only when you develop breathing issues or other symptoms of COPD. Please consult your doctor if you have questions about how long to continue your treatment.

Onbrez 150 mcg should not be used in patients with hypersensitivity to its active substance or other inactive ingredients. If immediate hypersensitive reactions have been reported after administration of Breezhaler, the treatment should be discontinued immediately and alternate treatment instituted. Signs suggesting allergic reaction include swelling of tongue/lips/face/tongue, skin rash, and urticaria.  

The Breezhaler is a long-acting beta2 adrenergic agonist, which is only used for COPD and should not be used in patients with asthma due to insufficient clinical evidence. Long-acting beta2 adrenergic agonists may increase your risk of serious asthma-related adverse effects, including asthma-related deaths, when used to reduce asthma symptoms.

Very common side effects of Onbrez 150 are:

 — Runny nose

 — Sore throat

 — Headache

 — Palpitations

 — Muscle spasms

 — Dizziness

 — Cough

 — Chest pain

 — Swollen hands/ankles and feet

 — Pain in muscles, bones, or joints

 — Itching/rash

If you get any side effects, please talk to your doctor. This includes any possible side effects not listed in this information guide.